Hormone replacement therapy drugs for men that suffer from low testosterone (also referred to as Low T), are associated with health risks, with the most serious being an increased risk of heart attack.
Numerous studies have linked testosterone replacement therapy (TRT) to a raised risk of cardiovascular problems. As such advocacy groups have called for a black-box warning on ALL testosterone packaging. These same groups have petitioned the FDA to require manufacturers of these drugs to include warnings on the packages that are already on the market.
Testosterone Therapy and Low T Drugs
Testosterone therapy is used to treat male hypogonadism (low testosterone) a condition in which the body doesn’t produce enough hormones due to a problem with the pituitary gland or testicles. In the U.S. population, 3 to 7 seven percent of men have hypogonadism.
Several prescriptions are available including – AndroGel, Androderm, Axiron, Delatestryl, Fortesta, Striant, Testim, Testopel and other androgen drugs. Since testosterone therapies are not proven treatments, experts caution that risks may outweigh benefits for healthy men.
Lawsuits Against Testosterone Manufacturers
Several suits raising the issue of testosterone and cardiovascular side effects have been in court. Just days after the agency issued a safety alert in early 2014, five men ranging in age, filed lawsuits in Chicago Federal Court against Abbott Laboratories and others makers of the drug AndroGel.
The suits alleged that three of the men suffered a heart attack after using AndroGel, one man had a stroke and another suffered a mini-stroke. They further contend that these companies deceived consumers by using aggressive and deceptive marketing practices that stressed the benefits and exaggerated the need while downplaying the serious risks.
What Patients Can Do
First and foremost seek medical help for any symptoms while using these products.
Next seek a no cost, no obligation consultation from a defective drug attorney such as Sheller P.C., that are representing men who have experienced a heart attack or stroke and families of loved ones that may have died while taking or after taking these testosterone supplements.